前立腺がんの若年発症を予測するゲノム診断手法を開発 --前立腺がんのゲノムワイド関連解析からゲノム医療へ--. 京都大学プレスリリース. 2019-10-08.Genome-wide association studies (GWAS) have identified ~170 genetic loci associated with prostate cancer (PCa) risk, but most of them were identified in European populations. We here performed a GWAS and replication study using a large Japanese cohort (9, 906 cases and 83, 943 male controls) to identify novel susceptibility loci associated with PCa risk. We found 12 novel loci for PCa including rs1125927 (TMEM17, P = 3.95 × 10−16), rs73862213 (GATA2, P = 5.87 × 10−23), rs77911174 (ZMIZ1, P = 5.28 × 10−20), and rs138708 (SUN2, P = 1.13 × 10−15), seven of which had crucially low minor allele frequency in European population. Furthermore, we stratified the polygeni...
Prostate cancer (PrCa) is the most common non-skin cancer diagnosed among males in developed countri...
Prostate cancer (PrCa) is the most frequently diagnosed male cancer in developed countries. To ident...
Genome-wide association studies (GWAS) and fine-mapping efforts to date have identified more than 10...
Genome-wide association studies (GWAS) have identified ~170 genetic loci associated with prostate ca...
Five novel prostate cancer risk loci were identified in a recent genome-wide association study (GWAS...
Background: A recent genome-wide association study (GWAS) of prostate cancer in a Japanese populatio...
Background There have been few genome-wide association studies (GWAS) of prostate cancer among di...
Prostate cancer (PrCa) is the most common non-skin cancer diagnosed among males in developed countri...
Genome-wide association studies (GWAS) have identifiedB100 genetic loci associated with prostate can...
Genome-wide association studies (GWAS) and fine-mapping efforts to date have identified more than 10...
Genome-wide association studies (GWAS) and fine-mapping efforts to date have identified more than 10...
Prostate cancer (PrCa) is the most common non-skin cancer diagnosed among males in developed countri...
Prostate cancer (PrCa) is the most frequently diagnosed male cancer in developed countries. To ident...
Genome-wide association studies (GWAS) and fine-mapping efforts to date have identified more than 10...
Genome-wide association studies (GWAS) have identified ~170 genetic loci associated with prostate ca...
Five novel prostate cancer risk loci were identified in a recent genome-wide association study (GWAS...
Background: A recent genome-wide association study (GWAS) of prostate cancer in a Japanese populatio...
Background There have been few genome-wide association studies (GWAS) of prostate cancer among di...
Prostate cancer (PrCa) is the most common non-skin cancer diagnosed among males in developed countri...
Genome-wide association studies (GWAS) have identifiedB100 genetic loci associated with prostate can...
Genome-wide association studies (GWAS) and fine-mapping efforts to date have identified more than 10...
Genome-wide association studies (GWAS) and fine-mapping efforts to date have identified more than 10...
Prostate cancer (PrCa) is the most common non-skin cancer diagnosed among males in developed countri...
Prostate cancer (PrCa) is the most frequently diagnosed male cancer in developed countries. To ident...
Genome-wide association studies (GWAS) and fine-mapping efforts to date have identified more than 10...